SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-151837
Filing Date
2017-05-01
Accepted
2017-05-01 16:13:28
Documents
3
Period of Report
2017-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d381540d8k.htm 8-K 17034
2 EX-99.1 d381540dex991.htm EX-99.1 56050
3 GRAPHIC g381540g0501231454995.jpg GRAPHIC 3984
  Complete submission text file 0001193125-17-151837.txt   79994
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 17800855
SIC: 2834 Pharmaceutical Preparations